QUINCE THERAPEUTICS, INC.
Ticker : QNCX
SEC Filings
Current Reports
Proxy Statements
DEFA14A
2024-04-24
Beneficial Ownership Report
13D
2024-11-13
Subsidiaries
EX-21.1
2024-04-01